Publications
2022
WHO essential medicines for children 2011-2019: age-appropriateness of enteral formulations
Orubu, E. S. F., Duncan, J., Tuleu, C., Turner, M. A., & Nunn, A. (2022). WHO essential medicines for children 2011-2019: age-appropriateness of enteral formulations. ARCHIVES OF DISEASE IN CHILDHOOD, 107(4), 317-322. doi:10.1136/archdischild-2021-321831
2019
Medicines prescription patterns in European neonatal units
Mesek, I., Nellis, G., Lass, J., Metsvaht, T., Varendi, H., Visk, H., . . . Lutsar, I. (2019). Medicines prescription patterns in European neonatal units. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 41(6), 1578-1591. doi:10.1007/s11096-019-00923-2
Making Medicines Baby Size: The Challenges in Bridging the Formulation Gap in Neonatal Medicine
O'Brien, F., Clapham, D., Krysiak, K., Batchelor, H., Field, P., Caivano, G., . . . Tuleu, C. (2019). Making Medicines Baby Size: The Challenges in Bridging the Formulation Gap in Neonatal Medicine. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 20(11). doi:10.3390/ijms20112688
2018
Accuracy of intravenous and enteral preparations involving small volumes for paediatric use: a review
Ainscough, L. P., Ford, J. L., Morecroft, C. W., Peak, M., Turner, M. A., Nunn, A. J., & Roberts, M. (2018). Accuracy of intravenous and enteral preparations involving small volumes for paediatric use: a review. EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 25(2), 66-71. doi:10.1136/ejhpharm-2016-001117
2017
A systematic review of the use of dosage form manipulation to obtain required doses to inform use of manipulation in paediatric practice
Richey, R. H., Hughes, C., Craig, J. V., Shah, U. U., Ford, J. L., Barker, C. E., . . . Turner, M. A. (2017). A systematic review of the use of dosage form manipulation to obtain required doses to inform use of manipulation in paediatric practice. International Journal of Pharmaceutics, 518(1-2), 155-166. doi:10.1016/j.ijpharm.2016.12.032
Development of the Liverpool Adverse Drug Reaction Avoidability Assessment Tool
Bracken, L., Nunn, A., Kirkham, J. J., Peak, M., Arnott, J., Smyth, R. L., . . . Turner, M. (2017). Development of the Liverpool Adverse Drug Reaction Avoidability Assessment Tool. PLoS ONE, 12(1). doi:10.1371/journal.pone.0169393
A Comprehensive List of Items to be Included on a Pediatric Drug Monograph.
Kelly, L. E., Ito, S., Woods, D., Nunn, A. J., Taketomo, C., de Hoog, M., & Offringa, M. (2017). A Comprehensive List of Items to be Included on a Pediatric Drug Monograph.. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 22(1), 48-59. doi:10.5863/1551-6776-22.1.48
2016
Essential medicines containing ethanol elevate blood acetaldehyde concentrations in neonates
Pandya, H. C., Mulla, H., Hubbard, M., Cordell, R. L., Monks, P. S., Yakkundi, S., . . . Consortium, E. S. N. E. E. (2016). Essential medicines containing ethanol elevate blood acetaldehyde concentrations in neonates. European Journal of Pediatrics, 175, 841-847. doi:10.1007/s00431-016-2714-x
Product Substitution as a Way Forward in Avoiding Potentially Harmful Excipients in Neonates
Nellis, G., Metsvaht, T., Varendi, H., Lass, J., Duncan, J., Nunn, A. J., . . . Lutsar, I. (2016). Product Substitution as a Way Forward in Avoiding Potentially Harmful Excipients in Neonates. PEDIATRIC DRUGS, 18(3), 221-230. doi:10.1007/s40272-016-0173-5
2015
Potentially harmful excipients in neonatal medicines: a pan-European observational study
Nellis, G., Metsvaht, T., Varendi, H., Toompere, K., Lass, J., Mesek, I., . . . Lutsar, I. (2015). Potentially harmful excipients in neonatal medicines: a pan-European observational study. Archives of Disease in Childhood, 100(7), 694-699. doi:10.1136/archdischild-2014-307793
High variability in the dosing of commonly used antibiotics revealed by a Europe-wide point prevalence study: implications for research and dissemination
Metsvaht, T., Nellis, G., Varendi, H., Nunn, A. J., Graham, S., Rieutord, A., . . . Lutsar, I. (2015). High variability in the dosing of commonly used antibiotics revealed by a Europe-wide point prevalence study: implications for research and dissemination. BMC Pediatrics, 15. doi:10.1186/s12887-015-0359-y
2014
Clinical coding of prospectively identified paediatric adverse drug reactions – a retrospective review of patient records
Bellis, J. R., Kirkham, J. J., Nunn, A. J., & Pirmohamed, M. (2014). Clinical coding of prospectively identified paediatric adverse drug reactions – a retrospective review of patient records. BMC PHARMACOLOGY & TOXICOLOGY, 15. doi:10.1186/2050-6511-15-72
Dexamethasone and haemorrhage risk in paediatric tonsillectomy: a systematic review and meta-analysis
Bellis, J., Pirmohamed, M., Nunn, A. J., Loke, Y. K., De, S., Golder, S., & Kirkham, J. J. (2014). Dexamethasone and haemorrhage risk in paediatric tonsillectomy: a systematic review and meta-analysis. British Journal of Anaesthesia, 113(1), 23-42. doi:10.1093/bja/aeu152
Risk assessment of neonatal excipient exposure: Lessons from food safety and other areas
Turner, M. A., Duncan, J. C., Shah, U., Metsvaht, T., Varendi, H., Nellis, G., . . . Nunn, A. J. (2014). Risk assessment of neonatal excipient exposure: Lessons from food safety and other areas. ADVANCED DRUG DELIVERY REVIEWS, 73, 89-101. doi:10.1016/j.addr.2013.11.003
Adverse drug reactions and off-label and unlicensed medicines in children: a prospective cohort study of unplanned admissions to a paediatric hospital
Bellis, J. R., Kirkham, J. J., Nunn, A. J., & Pirmohamed, M. (2014). Adverse drug reactions and off-label and unlicensed medicines in children: a prospective cohort study of unplanned admissions to a paediatric hospital. British Journal of Clinical Pharmacology, 77(3), 545-553. doi:10.1111/bcp.12222
ADRIC: Adverse Drug Reactions In Children – a programme of research using mixed methods
Smyth, R. L., Peak, M., Turner, M. A., Nunn, A. J., Williamson, P. R., Young, B., . . . Pirmohamed, M. (2014). ADRIC: Adverse Drug Reactions In Children – a programme of research using mixed methods.
2013
European Study of Neonatal Exposure to Excipients: An update
Turner, M. A., Duncan, J., Shah, U., Metsvaht, T., Varendi, H., Nellis, G., . . . Nunn, A. J. (2013). European Study of Neonatal Exposure to Excipients: An update. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 457(1), 357-358. doi:10.1016/j.ijpharm.2013.08.078
MODRIC - Manipulation of drugs in children
Richey, R. H., Craig, J. V., Shah, U. U., Nunn, A. J., Turner, M. A., Barker, C. E., . . . Peak, M. (2013). MODRIC - Manipulation of drugs in children. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 457(1), 339-341. doi:10.1016/j.ijpharm.2013.08.061
Adverse drug reactions and off-label and unlicensed medicines in children: a nested case-control study of inpatients in a pediatric hospital
Bellis, J. R., Kirkham, J. J., Thiesen, S., Conroy, E. J., Bracken, L. E., Mannix, H. L., . . . Pirmohamed, M. (2013). Adverse drug reactions and off-label and unlicensed medicines in children: a nested case-control study of inpatients in a pediatric hospital. BMC MEDICINE, 11. doi:10.1186/1741-7015-11-238
Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children - a prospective observational cohort study of 6,601 admissions
Thiesen, S., Conroy, E. J., Bellis, J. R., Bracken, L. E., Mannix, H. L., Bird, K. A., . . . Smyth, R. L. (2013). Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children - a prospective observational cohort study of 6,601 admissions. BMC MEDICINE, 11. doi:10.1186/1741-7015-11-237
Manipulation of drugs to achieve the required dose is intrinsic to paediatric practice but is not supported by guidelines or evidence
Richey, R. H., Shah, U. U., Peak, M., Craig, J. V., Ford, J. L., Barker, C. E., . . . Turner, M. A. (2013). Manipulation of drugs to achieve the required dose is intrinsic to paediatric practice but is not supported by guidelines or evidence. BMC PEDIATRICS, 13. doi:10.1186/1471-2431-13-81
What can we learn from parents about enhancing participation in pharmacovigilance?
Arnott, J., Hesselgreaves, H., Nunn, A. J., Peak, M., Pirmohamed, M., Smyth, R. L., . . . Young, B. (2013). What can we learn from parents about enhancing participation in pharmacovigilance?. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 75(4), 1109-1117. doi:10.1111/j.1365-2125.2012.04441.x
2012
Adverse Drug Reactions Causing Admission to a Paediatric Hospital
Gallagher, R. M., Mason, J. R., Bird, K. A., Kirkham, J. J., Peak, M., Williamson, P. R., . . . Smyth, R. L. (2012). Adverse Drug Reactions Causing Admission to a Paediatric Hospital. PLOS ONE, 7(12). doi:10.1371/journal.pone.0050127
Enhancing Communication about Paediatric Medicines: Lessons from a Qualitative Study of Parents' Experiences of Their Child's Suspected Adverse Drug Reaction
Arnott, J., Hesselgreaves, H., Nunn, A. J., Peak, M., Pirmohamed, M., Smyth, R. L., . . . Young, B. (2012). Enhancing Communication about Paediatric Medicines: Lessons from a Qualitative Study of Parents' Experiences of Their Child's Suspected Adverse Drug Reaction. PLOS ONE, 7(10). doi:10.1371/journal.pone.0046022
The manipulation of drugs to obtain the required dose: systematic review
Richey, R. H., Craig, J. V., Shah, U. U., Ford, J. L., Barker, C. E., Peak, M., . . . Turner, M. A. (2012). The manipulation of drugs to obtain the required dose: systematic review. JOURNAL OF ADVANCED NURSING, 68(9), 2103-2112. doi:10.1111/j.1365-2648.2011.05916.x
2011
Development and Inter-Rater Reliability of the Liverpool Adverse Drug Reaction Causality Assessment Tool
Gallagher, R. M., Kirkham, J. J., Mason, J. R., Bird, K. A., Williamson, P. R., Nunn, A. J., . . . Pirmohamed, M. (2011). Development and Inter-Rater Reliability of the Liverpool Adverse Drug Reaction Causality Assessment Tool. PLOS ONE, 6(12). doi:10.1371/journal.pone.0028096
Poster Session Abstracts
Poster Session Abstracts (2011). Pediatric Pulmonology, 46(S34), 212-428. doi:10.1002/ppul.21583
Adverse drug reactions causing admission to a paediatric hospital: a pilot study
Gallagher, R. M., Bird, K. A., Mason, J. R., Peak, M., Williamson, P. R., Nunn, A. J., . . . Smyth, R. L. (2011). Adverse drug reactions causing admission to a paediatric hospital: a pilot study. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 36(2), 194-199. doi:10.1111/j.1365-2710.2010.01194.x
2010
Components of risk associated with home intravenous antibiotic therapy (H-IVAT) in the UK
Glasscoe, C., Quittner, A. L., Patel, L., Dale, C., Burrows, E. F., Hope, H. F., . . . Nunn, A. J. (2010). Components of risk associated with home intravenous antibiotic therapy (H-IVAT) in the UK. Journal of Cystic Fibrosis, 9, S105. doi:10.1016/s1569-1993(10)60408-0
Points to consider when planning the collection of blood or tissue samples in clinical trials of investigational medicinal products in children, infants and neonates
Hawcutt, D. B., Rose, A. C., Fuerst-Rectenwald, S., Nunn, A. J., & Turner, M. A. (2010). Points to consider when planning the collection of blood or tissue samples in clinical trials of investigational medicinal products in children, infants and neonates. In K. Rose, & J. van den Anker (Eds.), Guide to Paediatric Drug Development and Clinial Research (pp. 96-110). Basel: Karger.
2009
Estimating risk associated with home-based intravenous antibiotic therapy (IVAT)
Glasscoe, C., Southern, K. W., Lancaster, G. A., Quittner, A. L., Burrows, E. F., Heaf, L. J., . . . Nunn, A. J. (2009). Estimating risk associated with home-based intravenous antibiotic therapy (IVAT). Journal of Cystic Fibrosis, 8, S95. doi:10.1016/s1569-1993(09)60368-4